PMID: 8587040Nov 1, 1995Paper

Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes

Journal of Pharmaceutical Sciences
R I MahatoM Hashida

Abstract

The objectives of this study were (i) to characterize the plasmid DNA encoding the chloramphenicol acetyltransferase reporter gene (pCAT) complexed with cationic liposomes (Lipofectin and LipofectACE) in terms of particle size and zeta potential, (ii) to compare pharmacokinetic characteristics, and (iii) to study the hepatic uptake mechanisms. DNA/LipofectACE complexes showed a negative zeta potential of -36 mV at 1:5 w/w ratio, but a positive zeta potential of (19 mV at 1:10 w/w ratio. Lipofectin samples showed a positive zeta potential) of 21-28 mV at these ratios. These preparations showed a wide particle size distribution ranging from 600 to 1200 nm. Following intravenous injection of 1:10 w/w ratio [32P]pCAT/liposome complexes at a dose of 0.1 mg DNA/kg into the tail vein of mice, radioactivity was rapidly eliminated from the plasma and almost 50-60% of the dose was taken up by the liver within 5 min after administration. Plasmid DNA/liposome complexes were predominantly taken up by the liver nonparenchymal cells. The hepatic uptake was inhibited by preceding administration of dextran sulfate (DS), but not by polycytidic acid (poly[C]) and polyinosinic acid (poly[I]), suggesting the involvement of a phagocytic process. We ...Continue Reading

References

Aug 1, 1987·Pharmaceutical Research·Y TakakuraH Sezaki
Jun 16, 1989·Science·T Friedmann
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·K R PatelJ D Baldeschwieler
Jan 1, 1995·Journal of Drug Targeting·R I MahatoM Hashida
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·P Tolstoshev

❮ Previous
Next ❯

Citations

Sep 11, 2002·The Journal of Gene Medicine·Makoto HiranoTakahisa Imamura
Apr 14, 2010·Pharmaceutical Research·Zinnia P Parra-GuillénIñaki F Trocóniz
Mar 11, 2005·Advanced Drug Delivery Reviews·Ram I Mahato
Dec 9, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ferry VerbaanChristien Oussoren
Apr 21, 1999·Biochimica Et Biophysica Acta·P PiresM C Pedroso de Lima
Nov 2, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·E PedoneG Giammona
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·R J MumperA P Rolland
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M HashidaY Takakura
Mar 22, 2001·Advanced Drug Delivery Reviews·C W Pouton, L W Seymour
Dec 18, 2001·Advanced Drug Delivery Reviews·R KircheisE Wagner
Nov 24, 2001·Advanced Drug Delivery Reviews·M HashidaY Takakura
Jun 6, 2000·Advanced Drug Delivery Reviews·P R Cullis, A Chonn
Jun 6, 2000·Advanced Drug Delivery Reviews·C W Pouton, L W Seymour
Jun 6, 2000·Advanced Drug Delivery Reviews·M B BallyD L Reimer
Jun 11, 1999·International Journal of Pharmaceutics·J C BirchallS N Mills
Mar 15, 2001·Critical Reviews in Oncology/hematology·H H Sedlacek
Apr 20, 2002·Drug Discovery Today·Manfred Ogris, Ernst Wagner
Sep 2, 1999·Pharmaceutical Science & Technology Today·A V Kabanov
Dec 5, 2008·Bioconjugate Chemistry·Lin ZhuRam I Mahato
Jun 2, 2001·Human Gene Therapy·M Nishikawa, L Huang
Apr 29, 1998·The Journal of Clinical Investigation·G ThurstonD M McDonald
Dec 15, 2010·International Archives of Medicine·Faisal A Al-AllafMichael Themis
Mar 27, 2002·Biological & Pharmaceutical Bulletin·Makiya Nishikawa, Mitsuru Hashida
Jul 5, 2006·Biological & Pharmaceutical Bulletin·Takahiro FujiwaraHideyoshi Harashima
Aug 5, 2005·Chemical & Pharmaceutical Bulletin·Mitsuru HashidaFumiyoshi Yamashita
May 20, 1999·Molecular Membrane Biology·N MaurerP R Cullis
Nov 8, 2001·Journal of Drug Targeting·J M BennsS W Kim
Jan 1, 1997·Journal of Drug Targeting·R I MahatoM Hashida
Nov 18, 2014·Expert Opinion on Biological Therapy·Hojat BornaSadegh Azimzadeh Jamalkandi
Jul 5, 2005·Expert Opinion on Investigational Drugs·J WuM A Zern
Jul 25, 2014·BioMed Research International·Gyati Shilakari AsthanaSuresh Prasad Vyas
Feb 26, 2008·Cancer Science·Makiya NishikawaMitsuru Hashida
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andreas G SchatzleinIjeoma F Uchegbu
Aug 27, 2016·Drug Delivery and Translational Research·Jamie L Betker, Thomas J Anchordoquy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.